title: [Anticonvulsant hypersensitivity syndrome with severe repercussions in the skin and kidneys due to carbamazepine].
abstract: BACKGROUND
  Anticonvulsant hypersensitivity syndrome (AHS) is characterised by fever, skin rashes and involvement of the internal organs. Owing to the low frequency with which it appears and its high clinical heterogeneity, it is not always suspected. Moreover, the symptoms often overlap with those of a vasculitis or of an infection. The most commonly associated antiepileptic drugs (AED) are the aromatic agents. We report the case of a female patient who developed AHS with several different AED and presented an especially severe kidney and skin disorder due to carbamazepine (CBZ).
  
  
  METHODS
  We describe the case of a 26-year-old woman who, after being diagnosed as suffering from secondarily generalised partial seizures, began treatment with 200 mg/12 hours CBZ. A few weeks later, she developed itchy skins lesions compatible with exanthematic pustulosis, together with acute kidney failure requiring haemodialysis. A biopsy study of the kidney revealed immunoallergic tubulointerstitial nephropathy, which is a lesion that has only very occasionally been reported in relation to CBZ therapy. The patient also presented a moderate rise in the level of transaminases and leukocytosis with eosinophilia. She was discharged from hospital without AED but suffered new seizures and was treated with phenytoin and, later, with valproic acid, both as monotherapy. With these drugs she developed AHS consisting in fever, rashes, eosinophilia and subclinical hepatitis. In epicutaneous tests with anticonvulsants, the three AED presented a positive reading, as well as others. The patient was treated with tiagabine, and there were no further hypersensitivity phenomena and a good control of seizures was achieved.
  
  
  CONCLUSIONS
  AHS is an infrequent, but potentially serious, clinical entity and must therefore be suspected in patients taking AED who develop fever, rashes or disorders affecting the internal organs.
authors.affiliation: Servicio de Neurología, Hospital Universitario Virgen Macarena, Sevilla, Spain. jaduran@us.es
authors.forename: E
authors.initials: E
authors.lastname: Durán-Ferreras
authors.forename: J
authors.initials: J
authors.lastname: Mir-Mercader
authors.forename: M D
authors.initials: MD
authors.lastname: Morales-Martínez
authors.forename: C
authors.initials: C
authors.lastname: Martínez-Parra
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D002220:Carbamazepine / Q000009:adverse effects* / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000175:diagnosis; D004827:Epilepsy / Q000188:drug therapy; D005076:Exanthema / Q000139:chemically induced*; D005260:Female; D006801:Humans; D009395:Nephritis, Interstitial / Q000139:chemically induced*; D016896:Treatment Outcome
chemical_list: D000927:Anticonvulsants; D002220:Carbamazepine